rheumatology geriatrics general-medicine
QFracture — 10-Year Osteoporotic Fracture Risk
QFracture estimates the 10-year risk of hip fracture and of major osteoporotic fracture (hip, spine, wrist, shoulder) in people aged 30–99 from UK primary-care data. NICE CG146 recommends QFracture or FRAX for fracture risk assessment. This page explains how to use it.
Used in: Osteoporosis
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Denosumab · Anti-RANKL Monoclonal Antibody
- Denosumab · RANK Ligand Inhibitor (Anti-resorptive)
- Alendronic Acid (Alendronate) · Bisphosphonate (bone resorption inhibitor)
- Zoledronic Acid · IV Bisphosphonate
- Ciprofloxacin with dexamethasone · Topical otic antibiotic + corticosteroid
- Zoledronic Acid · Bisphosphonate
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
